top of page
Media Center


enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project
enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project News-ReleasesEnGenes Biotech GmbH May 3rd 2023...


enGenes provides a high-quality protein expression platform for cost-effective biomolecule manufacture
enGenes provides a high-quality protein expression platform for cost-effective biomolecule manufacture Products-ServicesEnGenes Biotech...


enGenes Biotech to make debut at Swiss Biotech Day conference
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will make its debut at the upcoming annual Swiss...


Study indicates enGenes Biotech’s Shiga Toxin B subunits useful as drug carriers in cancer therapy
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has led a new study investigating potential...


enGenes Biotech bringing enhanced product yield opportunities to BIO-Europe Autumn in Germany
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will present its latest technologies at the...


enGenes Biotech makes debut at ICB V continuous biomanufacturing event
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will make its debut at the 5th Integrated...


enGenes development and manufacturing support
enGenes Biotech offers development and manufacturing support services that are highly relevant to companies wishing to develop...


enGenes Biotech to showcase enzyme production offers at Chemspec Europe
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will use the reconvened physical Chemspec Europe...


enGenes participates in the study of large scale production strategies for microbial carbohydrate-binding toxins
Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have collaborated with researchers...


enGenes Biotech joins TU Munich to study cost-effective protein purification by magnetic nanoparticles
Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have co-authored a new study that...
bottom of page